Teva Pharmaceutical Industries | TEVA - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd reported $3.66B in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
Aspen Pharmacare APN:SJ ZAR 19.15B 75M
Cipla CIPLA:IN INR 57.39B 707.9M
Dr.Reddys Laboratories DRRD:IN INR 62.97B 4.93B
Guangzhou Baiy 600332:CH CNY 21.63B 5.65B
Jiangsu Hengrui Me. 600276:CH CNY 5.49B 162.35M
Kalbe Farma KLBF:IJ IDR 7.87T 117.43B
Richter Gedeon RICHT:HB HUF 209.65B 14.32B
Sh Fosun Pharma 600196:CH CNY 10.87B 1.47B
Sun Pharmaceuticals SUNP:IN INR 109.31B 3.1B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 3.66B 223M